M&A
confidence high
sentiment positive
materiality 0.80
Waystar Holding Corp. (WAY): debt financing — Waystar closes Iodine acquisition for ~$459M cash + 16.6M shares; debt amended
Waystar Holding Corp.
- Acquisition completed Oct 1, 2025; total consideration ~$458.6M cash plus 16.64M shares valued at $37.31/share.
- Combined company unites financial and clinical AI; expands TAM by >15% with Iodine's 1,000+ hospital clients.
- Waystar expects immediate accretion to gross margin and adjusted EBITDA margin; revenue and non-GAAP EPS accretive in 2027.
- Credit facility amended: $250M incremental term loans, revolver increased to $500M, interest rates reduced.
- Board expanded to 13; Lauren Young (Advent MD) appointed as Class II director.